Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Akari therapeutics plc    crawled date : 2021 - 02 - 25    save search
Akari Therapeutics Presents New Preclinical Data Highlighting Potential of Long-Acting PASylated Nomacopan to Treat Retinal Diseases, Including Age-Related Macular Degeneration (AMD) and Uveitis
Published: 2021-02-25 (Crawled : 15:00) - biospace.com/
AKTX | $1.11 -8.26% 2.8K twitter stocktwits trandingview |
Health Technology
 | | O: 2.31% H: 1.69% C: -6.21%
disease retina macular potential dmd preclinical pre-clinical
Gainers vs Losers
76% 24%

Top 10 Gainers
AGBA | News | $1.22 205.0% 86M twitter stocktwits trandingview |
Finance
EGOX | $0.054 50.0% 290M twitter stocktwits trandingview |

CHRO | $1.66 35.51% 70K twitter stocktwits trandingview |
n/a
INDO | $5.43 33.09% 10M twitter stocktwits trandingview |
Energy Minerals
NVFY | $2.71 28.44% 31M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.86 28.28% 29M twitter stocktwits trandingview |
Commercial Services
RWOD | $10.08 26.05% 5.6M twitter stocktwits trandingview |
n/a
HUSA 4 | $2.07 23.95% 2.1M twitter stocktwits trandingview |
Energy Minerals
TPET | $0.4001 22.02% 35M twitter stocktwits trandingview |
n/a
SRFM 4 | $0.6 21.29% 850K twitter stocktwits trandingview |
n/a
Your saved searches
Save your searches and get alerts when important news are released.